- Home
- REE vs SCNX Comparison
REE vs SCNX Comparison
Compare REE & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REE | SCNX |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | Israel | United States |
| Employees | N/A | 19 |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 19.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | REE | SCNX |
|---|---|---|
| Price | $0.53 | $0.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.50 | $1.50 |
| AVG Volume (30 Days) | 45.9K | ★ 2.2M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $327.73 | $347.88 |
| Revenue Next Year | $36,888.82 | $744.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $0.37 |
| 52 Week High | $3.76 | $2.60 |
Technical Indicators
Market Signals| Indicator | REE | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 47.05 |
| Support Level | $0.53 | $0.39 |
| Resistance Level | $0.74 | $0.47 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 46.94 | 29.25 |
Price Performance
Historical ComparisonAbout REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.